Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico

Medical Mycology

Volumn 50, Issue 7, 2012, Pages 781-784

  Treviño Rangel, Rogelio De J ^a   Garza González, Elvira ^a   González, J Gerardo ^a   Bocanegra García, Virgilio ^b   Llaca, Jorge M ^a   González, Gloria M ^a  

^a Medicina UANL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antifungal susceptibility; Candida metapsilosis; Candida orthopsilosis; Candida parapsilosis; Candidosis

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; MICAFUNGIN;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA PARAPSILOSIS SENSU STRICTO; FUNGUS ISOLATION; IN VITRO STUDY; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; GENETIC VARIATION; HUMANS; MEXICO; MICROBIAL SENSITIVITY TESTS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS;

EID: 84866483797     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.675526     Document Type: Article

References (22)

1. Almirante B, Rodríguez D, Cuenca-Estrella M, et al . Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbio 2006; 44: 1681-1685.
2. Tortorano AM, Peman J, Bernhardt H, et al . Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-322.
3. González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: Results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 2008; 46: 2902-2905.
4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163.
5. van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007; 164: 287-293.
6. Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005; 43: 284-292.
7. Pfaller MA, Boyken L, Hollis RJ, et al . In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance. J Clin Microbiol 2008; 46: 150-156.
8. Sarvikivi E, Lyytikainen O, Soll DR, et al . Emergence of fl uconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 2005; 43: 2729-2735.
9. Clinical and Laboratory Standards Institute. R eference Method for- Broth Dilution Antifungal Susceptibility Testing of Yeasts . Approved standard M27-A3, 3rd edn. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
10. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. Wild-type MIC distributions, epidemiological cutoff values and species-specifi c clinical breakpoints for fl uconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat 2010; 13: 180-195.
11. Pfaller MA, Diekema DJ, Andes D, et al . Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specifi c interpretive criteria. Drug Resist Updat 2011; 14: 164-176.
12. de Toro M, Torres MJ, Maite R, Aznar J. Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect 2011; 17: 418-424.
13. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis . J Clin Microbiol 2008; 46: 2659-2664.
14. Gomez-Lopez A, Alastruey-Izquierdo A, Rodriguez D, et al . Prevalence and susceptibility profi le of Candida metapsilosis and Candida orthopsilosis: Results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother 2008; 52: 1506-1509.
15. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profi les of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J Clin Microbiol 2009; 47: 2392-2397.
16. Bonassoli LA, Bertoli M, Svidzinski TI. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect 2005; 59: 159-162.
17. Trofa D, Gác ser A, Nosanchuk JD. C andida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606-625.
18. Tavanti A, Hensgens LA, Ghelardi E, Campa M, Senesi S. Genotyping of Candida orthopsilosis clinical isolates by amplifi cation fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J Clin Microbio 2007; 45: 1455-1462.
19. Feng X, Ling B, Yang G, Yu X, Ren D, Yao Z. Prevalence and distribution profi les of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis responsible for superfi cial candidiasis in a chinese university hospital. Mycopathologia 2012; 173: 229-234.
20. Cantón E, Espinel-Ingroff A, Peman J, del Castillo L. I n vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob Agents Chemother 2010; 54: 2194-2197.
21. Pfaller MA, Boyken L, Hollis RJ, et al . In vitro susceptibilities of Candida spp. to caspofungin: Four years of global surveillance. J Clin Microbiol 2006; 44: 760-763.
22. Sanguinetti M, Posteraro P, Posteraro B. Echinocandin antifungal drug resistance in Candida species: A cause for concern? Curr Infec Dis Rep 2010; 12: 437-443.